Article
Exploring the evolving landscape of cell and gene therapies: Insights from Pharma USA 2024
Cell and gene therapies (CGTs) took center stage this year at Reuters Pharma USA in Philadelphia, with Vice President and Head of Cell and Gene Therapy, Lung-I Cheng, chairing the CGT track. During the event, pharmaphorum editor-in-chief Jonah Comstock caught up with Lung-I to get an update on the field and a look into recent changes.
Watch the recording to learn more about the current momentum in the US post regulatory approvals, the need for industry standardization and simplification of workflows to prepare for upcoming approvals. The conversation also covers payment system adaptations for one-time reimbursements in CGT, challenges in value-based contracts, innovative solutions, and Cencora’s upcoming virtual summit on CGT: ThinkLive Cell and Gene Therapy Summit.
Watch the recording to learn more about the current momentum in the US post regulatory approvals, the need for industry standardization and simplification of workflows to prepare for upcoming approvals. The conversation also covers payment system adaptations for one-time reimbursements in CGT, challenges in value-based contracts, innovative solutions, and Cencora’s upcoming virtual summit on CGT: ThinkLive Cell and Gene Therapy Summit.
